Big biology experiments often drown in numbers. When researchers test blood values across half-a-million people, tiny differences that mean nothing in real life can show up as headline-grabbing “statistically significant” findings simply because the sample size is huge. A new twist on the classic t-
In the world of cancer treatment, there is a lot of excitement about anti-PD-1 antibodies. These are used to fight various cancers, including advanced kidney cancer, also known as renal cell carcinoma. But here is the thing: not everyone responds to these treatments in the same way. Some people see
Welcome to the Stockholm Early Detection of Cancer Study, commonly known as STEADY-CAN. This unique project focuses on understanding how to spot cancer early in a large group of people from Stockholm County, Sweden. By gathering real-life medical data from both hospital and clinic visits, researcher
